Starting TRT is one decision. Getting it right is another.
Most men who begin testosterone therapy feel noticeably better in the first 4–8 weeks. But somewhere between month 3 and month 12, a significant portion plateau — or feel like the original improvement has faded. Labs look "fine." The clinic says everything looks good. But something still feels off.
This is a protocol optimization problem, not a TRT failure.
TRT has 9 adjustable variables. Most men are only ever given 1 or 2 options. Understanding all of them — and how they interact — is the difference between "tolerable" and "actually working."
🧭 Not sure where your protocol gap is?
The quiz maps your situation to the most likely optimization lever — before you change your dose.
Take the Free TRT Quiz →Why "Labs Look Fine" Doesn't Mean Your Protocol Is Optimal
The standard clinic interpretation framework is built around avoiding danger, not achieving function.
A total testosterone of 500 ng/dL at trough is "in range." So is 480 ng/dL 36 hours after your last injection while you're injecting once a week and riding a trough valley. Both pass the screening. Neither tells you whether your free testosterone is adequate, whether your E2 is crashed, or whether your injection frequency is creating a 5-day symptom cycle.
The goal of protocol optimization isn't to fix a "bad" result. It's to systematically evaluate whether each variable is calibrated for you specifically — not the median range on a lab reference sheet.
The 9-Variable TRT Protocol Optimization Stack
Variable 1: Lab Draw Timing
This is the most common optimization error and the one that produces the most misleading data.
The problem: Drawing labs at different times relative to your injection produces wildly different total T readings on the same protocol. A man on 100 mg testosterone cypionate once weekly will see:
- Peak (24–48 hrs post-injection): 900–1,200 ng/dL
- Midpoint (3–4 days): 600–800 ng/dL
- Trough (6–7 days): 350–500 ng/dL
If one draw catches him at trough and the next at midpoint, the lab looks like his dose doubled. This is not a clinical change. It's a timing artifact.
The fix: Always draw at the same time relative to injection. For twice-weekly injection, draw immediately before your next injection (trough). For once-weekly, draw 5–7 days after injection (trough). For daily SubQ, draw 12–24 hours after the last injection.
| Draw Type | Target Total T | Notes |
|---|---|---|
| Trough (twice-weekly IM) | 500–800 ng/dL | Adequate floor; peak ~1,000–1,200 |
| Trough (once-weekly IM) | 400–700 ng/dL | If below 400 at trough: dose or frequency issue |
| Daily SubQ steady-state | 550–850 ng/dL | Minimal variation; draw anytime after day 7 |
| Oral testosterone (with food) | 450–900 ng/dL | Draw 4–6 hrs post-dose |
See the complete bloodwork guide: TRT Bloodwork Panel: What to Draw and When →
Variable 2: Injection Frequency
This is the single most impactful lever most men never adjust.
Most clinics start patients on once-weekly injections. For many men, this creates a level cycle that produces noticeable symptom fluctuation: feeling good on days 2–4, declining on days 5–7.
The fix is usually not a higher dose — it's more frequent, smaller doses that flatten the curve.
| Injection Frequency | Peak-to-Trough Ratio | Typical Trough | Symptom Cycling Risk |
|---|---|---|---|
| Once weekly IM | ~2.5–3.5x | Often 350–500 ng/dL | High (days 5–7) |
| Twice-weekly IM | ~1.5–2x | 500–700 ng/dL | Moderate |
| Every other day IM | ~1.2–1.5x | 600–750 ng/dL | Low |
| Daily SubQ | ~1.1–1.3x | 550–800 ng/dL | Very low |
Who benefits most from increasing frequency:
- Men who track energy/libido/mood and notice cyclical drops
- Men with high hematocrit (smaller doses reduce peak erythropoietic stimulus)
- Men with E2 volatility (smaller, more frequent doses produce more stable aromatization)
- Men using HCG (EOD or daily SubQ pairs naturally with HCG timing)
Injection site technique guide: Testosterone Injection Sites: IM vs SubQ Guide →
Variable 3: Free Testosterone and SHBG
You can have a total testosterone of 700 ng/dL and functionally inadequate free testosterone.
How it happens: Sex hormone-binding globulin (SHBG) binds testosterone and renders it biologically inactive. If SHBG is high, your "normal" total T may deliver a functionally low free T.
| Lab | Optimization Target | Notes |
|---|---|---|
| Total testosterone | 500–900 ng/dL (trough) | Context-dependent; free T matters more |
| Free testosterone | >15 pg/mL (>2% of total) | Dial to symptom response, not population median |
| SHBG | 20–40 nmol/L | Above 50: high-SHBG protocol may be needed |
When SHBG exceeds 50 nmol/L, options include: more frequent injections, oral testosterone (Jatenzo/Kyzatrex actively suppresses SHBG), or addressing root causes like thyroid dysfunction or elevated SHBG from fasting.
Full SHBG explainer: High SHBG and Low Free Testosterone → | Free vs. Total Testosterone: Which Number Actually Matters →
Variable 4: Estradiol Management
The most common protocol failure on TRT is not inadequate testosterone. It's inadequate E2 management — in both directions.
Symptoms of high E2 (>50 pg/mL): Water retention, mood volatility, emotional blunting, nipple sensitivity, soft erections
Symptoms of crashed E2 (<10 pg/mL — often from anastrozole overuse): Joint pain, dry skin, poor erections, cognitive fog, low libido despite normal T, mood crashes
| Zone | E2 (sensitive assay) | Clinical Meaning |
|---|---|---|
| Crashed | <10 pg/mL | Active harm to erections, joints, bone |
| Suboptimal | 10–20 pg/mL | Often still symptomatic |
| Functional | 20–40 pg/mL | Optimal for most men |
| Elevated | 40–60 pg/mL | Monitor; protocol adjustment before AI |
| High | >60 pg/mL | Anastrozole may be justified if symptomatic |
Before adding or increasing anastrozole: Increase injection frequency first, reduce body fat, optimize dose. Use sensitive LC/MS estradiol assay (Quest #30289), not standard immunoassay.
⚠️ E2 optimization matters more than most men realize
Crashed estradiol from over-prescribed anastrozole is one of the most common causes of TRT failure. The quiz can help identify if this matches your pattern.
Take the Free TRT Quiz →Full anastrozole guide: Anastrozole on TRT: When You Actually Need It →
Variable 5: Dose Calibration
Most TRT protocols start at 100 mg/week testosterone cypionate. This is a reasonable starting point — not an optimized destination.
| Trough T (consistent timing) | Interpretation | Action |
|---|---|---|
| <450 ng/dL | Under-replaced | Increase dose 10–20% or increase frequency |
| 450–700 ng/dL | Therapeutic range | Optimize other variables before adjusting dose |
| 700–900 ng/dL | High-normal | Acceptable if asymptomatic and labs clean |
| >900 ng/dL at trough | Over-replaced | Reduce dose; check injection frequency |
Critical rule: Never change dose and frequency simultaneously. Change one variable, wait 6–8 weeks, retest. See full dosage guide: TRT Dosage: Starting Dose and Titration →
Variable 6: Delivery Method
Most men start on cypionate injections. Some patterns warrant delivery method reconsideration:
| Symptom/Pattern | Consider |
|---|---|
| High SHBG resistant to protocol changes | Oral TRT (Jatenzo/Kyzatrex) — SHBG-suppressive |
| Persistent level cycling despite twice-weekly IM | Daily SubQ micro-dosing |
| Hematocrit elevation (>52%) | Switch from once-weekly to twice-weekly or daily SubQ |
| Needle aversion, skin/transfer not a concern | Topical gel (note transfer risk and non-responder rate ~5–10%) |
Variable 7: Hematocrit Management
Testosterone stimulates EPO production, raising red blood cell mass. Unmanaged, hematocrit above 52–54% increases blood viscosity.
| Hematocrit | Action |
|---|---|
| <50% | Monitor quarterly; no intervention |
| 50–52% | Increase frequency to reduce peak stimulus; ensure hydration |
| 52–54% | Reduce dose or frequency; investigate sleep apnea; consider phlebotomy |
| >54% | Hold TRT; therapeutic phlebotomy; hematology consult |
Before blaming TRT dose: Rule out undiagnosed sleep apnea (independent EPO stimulus), dehydration at draw time, and insufficient CPAP pressure.
Variable 8: Add-On Protocol Variables
Some men optimize by removing things, not adding. Common add-ons worth evaluating:
- HCG: Appropriate for men concerned about testicular atrophy or fertility. Adds E2 volatility and cost without improving symptom response in men not bothered by atrophy. See: HCG on TRT →
- Anastrozole: Reserve for confirmed E2 >50–60 pg/mL with symptoms, after protocol optimization. Not a prophylactic.
- Gonadorelin: Compounding-legal HCG alternative. Potential fertility advantage via FSH stimulation. See: Gonadorelin on TRT →
Variable 9: Optimization Timeline Discipline
The most common optimization mistake: changing a variable, waiting 3 weeks, deciding it's not working, changing something else.
Testosterone cypionate takes 4–6 half-lives to reach steady-state (~6–8 weeks). Labs before steady-state are not valid for calibration. Adding variables before the current change stabilizes makes causation impossible to assign.
Protocol for any single variable change:
- Change one variable (dose, frequency, or add/remove a medication)
- Wait 6 weeks minimum before any further changes
- Draw labs at consistent timing (trough draw, same day of week)
- Compare labs AND subjective symptom score
- Hold steady if improved; continue iteration if not
The Systematic Optimization Audit: 5-Step Protocol
If you feel suboptimal on TRT, run this audit before changing anything:
- Lab Timing Audit — Were your last 2–3 labs drawn at consistent timing? If no → redraw correctly before drawing any clinical conclusions.
- Free T and SHBG Check — Is free testosterone >15 pg/mL? Is SHBG in range? If free T is low on "normal" total T → this is the lever.
- E2 Audit — Is E2 measured with sensitive LC/MS assay? Is it in the 20–40 pg/mL zone? If crashed → look at anastrozole. If high → injection frequency and body composition first.
- Frequency Evaluation — Are you injecting once-weekly and experiencing cyclical symptoms? If yes → twice-weekly is the highest-leverage, lowest-risk change.
- Hematocrit Check — Is hematocrit <50%? If elevated → frequency optimization and sleep apnea screening before dose reduction.
Only after completing this 5-step audit should dose changes be considered. For detailed troubleshooting of specific failure patterns, see: Why Isn't My TRT Working? →
Common Protocol Mistakes and Fixes
| Mistake | What It Looks Like | Fix |
|---|---|---|
| Inconsistent lab timing | Total T swings 200+ ng/dL between draws on same dose | Standardize trough draw timing |
| Anastrozole at standard clinic dose (0.5–1 mg 2x/wk) | Joint pain, poor erections, fog | Reduce or eliminate AI; check sensitive E2 |
| Once-weekly IM with symptom cycling | Feels good days 2–4, declines days 5–7 | Switch to twice-weekly or EOD |
| Normal total T + persistent symptoms | Fatigue, libido, mood unchanged | Check free T, SHBG, E2 before assuming TRT failure |
| Changing dose and frequency simultaneously | Can't determine what worked | One variable at a time; 6-week evaluation window |
FAQ
How long does it take to see results from a protocol adjustment?
Full steady-state from any single change takes 6–8 weeks for testosterone cypionate or enanthate. Noticeable subjective changes may come sooner, but lab calibration requires the full window.
My doctor says my labs are fine but I still feel off. What's wrong?
"Fine" means within range. Optimization is about finding where you function best. The most common culprits are lab draw timing artifacts, suboptimal free T from SHBG, and E2 that's either crashed (from AI) or elevated without reaching the clinical threshold for concern.
Can I optimize TRT by increasing my dose?
Dose is rarely the first lever. Most men with suboptimal results benefit more from frequency adjustment, E2 management, and free T evaluation than from increasing dose. Higher doses increase erythrocytosis and E2 risks without proportionally improving outcomes for men already in the 500–900 ng/dL range.
Is daily SubQ really better than twice-weekly IM?
For level stability, yes. Whether it matters clinically depends on whether you experience symptom cycling on twice-weekly. Many men do excellently on twice-weekly IM with no benefit from further frequency increases.
My E2 is at 55 pg/mL. Should I take anastrozole?
Not immediately. First check whether you have E2-related symptoms. If asymptomatic, the correct response is monitoring plus frequency optimization — not an aromatase inhibitor. Many men tolerate E2 up to 60–70 with no symptoms and fare worse when suppressed.
I have high SHBG. What's the best delivery method?
Oral testosterone (Jatenzo or Kyzatrex) is the only delivery method that directly suppresses SHBG as a pharmacological effect. Daily SubQ also helps modestly. Standard weekly IM is least effective for high-SHBG men because it creates peaks that partially stimulate further SHBG production.
When should I add HCG to my TRT protocol?
If testicular atrophy is bothersome, fertility is a concern, or libido remains suboptimal after other variables are optimized. HCG is not a universal addition — it adds E2 volatility and cost for benefits most men don't clinically need.
What if I've optimized all variables and still feel suboptimal?
If 2–3 full 6-week optimization cycles haven't produced improvement, the issue may be non-hormonal: sleep apnea, thyroid dysfunction, metabolic disorder, or psychological factors. A full extended workup is warranted before further TRT changes.
🧭 Ready to find your protocol gap?
TRT, enclomiphene, or optimization first — the quiz maps your situation to the right next step.
Take the Free TRT Quiz →For men already on TRT with persistent symptoms: Why Isn't My TRT Working? → | For the full dosage and titration guide: TRT Dosage → | For SHBG deep-dive: High SHBG and Low Free T → | For anastrozole: Anastrozole on TRT → | For cognitive function on TRT: Testosterone and Cognitive Function →